Benzinga | May 4, 2021 07:33AM EDT

Neuronetics Q1 EPS $(0.31), Inline, Sales $12.29M Beat $11.58M Estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.31) per share which met the analyst consensus estimate. This is a 54.41 percent increase over losses of $(0.68) per share from the same period last year. The company reported quarterly sales of $12.29 million which beat the analyst consensus estimate of $11.58 million by 6.11 percent. This is a 7.08 percent increase over sales of $11.48 million the same period last year.